189 related articles for article (PubMed ID: 8705862)
1. Alternatively spliced mdm2 transcripts with loss of p53 binding domain sequences: transforming ability and frequent detection in human cancer.
Sigalas I; Calvert AH; Anderson JJ; Neal DE; Lunec J
Nat Med; 1996 Aug; 2(8):912-7. PubMed ID: 8705862
[TBL] [Abstract][Full Text] [Related]
2. Expression of alternatively spliced mdm2 transcripts correlates with stabilized wild-type p53 protein in human glioblastoma cells.
Kraus A; Neff F; Behn M; Schuermann M; Muenkel K; Schlegel J
Int J Cancer; 1999 Mar; 80(6):930-4. PubMed ID: 10074928
[TBL] [Abstract][Full Text] [Related]
3. Alternative and aberrant messenger RNA splicing of the mdm2 oncogene in invasive breast cancer.
Lukas J; Gao DQ; Keshmeshian M; Wen WH; Tsao-Wei D; Rosenberg S; Press MF
Cancer Res; 2001 Apr; 61(7):3212-9. PubMed ID: 11306511
[TBL] [Abstract][Full Text] [Related]
4. Alternative and aberrant splicing of MDM2 mRNA in human cancer.
Bartel F; Taubert H; Harris LC
Cancer Cell; 2002 Jul; 2(1):9-15. PubMed ID: 12150820
[TBL] [Abstract][Full Text] [Related]
5. An alternative splice form of Mdm2 induces p53-independent cell growth and tumorigenesis.
Steinman HA; Burstein E; Lengner C; Gosselin J; Pihan G; Duckett CS; Jones SN
J Biol Chem; 2004 Feb; 279(6):4877-86. PubMed ID: 14612455
[TBL] [Abstract][Full Text] [Related]
6. Short alternative splice transcripts of the mdm2 oncogene correlate to malignancy in human astrocytic neoplasms.
Matsumoto R; Tada M; Nozaki M; Zhang CL; Sawamura Y; Abe H
Cancer Res; 1998 Feb; 58(4):609-13. PubMed ID: 9485008
[TBL] [Abstract][Full Text] [Related]
7. Tumor promotion by Mdm2 splice variants unable to bind p53.
Fridman JS; Hernando E; Hemann MT; de Stanchina E; Cordon-Cardo C; Lowe SW
Cancer Res; 2003 Sep; 63(18):5703-6. PubMed ID: 14522887
[TBL] [Abstract][Full Text] [Related]
8. Expression of MDM2 during mammary tumorigenesis.
Pinkas J; Naber SP; Butel JS; Medina D; Jerry DJ
Int J Cancer; 1999 Apr; 81(2):292-8. PubMed ID: 10188733
[TBL] [Abstract][Full Text] [Related]
9. The tumor suppressor p53 and the oncoprotein simian virus 40 T antigen bind to overlapping domains on the MDM2 protein.
Brown DR; Deb S; Muñoz RM; Subler MA; Deb SP
Mol Cell Biol; 1993 Nov; 13(11):6849-57. PubMed ID: 8413278
[TBL] [Abstract][Full Text] [Related]
10. p76(MDM2) inhibits the ability of p90(MDM2) to destabilize p53.
Perry ME; Mendrysa SM; Saucedo LJ; Tannous P; Holubar M
J Biol Chem; 2000 Feb; 275(8):5733-8. PubMed ID: 10681559
[TBL] [Abstract][Full Text] [Related]
11. Expression of alternatively and aberrantly spliced transcripts of the MDM2 mRNA is not tumor-specific.
Bartel F; Pinkert D; Fiedler W; Kappler M; Würl P; Schmidt H; Taubert H
Int J Oncol; 2004 Jan; 24(1):143-51. PubMed ID: 14654951
[TBL] [Abstract][Full Text] [Related]
12. Abundant expression of spliced HDM2 in Hodgkin lymphoma cells does not interfere with p14(ARF) and p53 binding.
Stürzenhofecker B; Schlott T; Quentin T; Kube D; Jung W; Trümper L
Leuk Lymphoma; 2003 Sep; 44(9):1587-96. PubMed ID: 14565663
[TBL] [Abstract][Full Text] [Related]
13. Expression of alternatively-spliced MDM2 transcripts in giant cell tumours of bone.
Evdokiou A; Atkins GJ; Bouralexis S; Hay S; Raggatt LJ; Cowled PA; Graves SE; Clayer M; Findlay DM
Int J Oncol; 2001 Sep; 19(3):625-32. PubMed ID: 11494046
[TBL] [Abstract][Full Text] [Related]
14. Genomic organisation of the human MDM2 oncogene and relationship to its alternatively spliced mRNAs.
Liang H; Atkins H; Abdel-Fattah R; Jones SN; Lunec J
Gene; 2004 Sep; 338(2):217-23. PubMed ID: 15315825
[TBL] [Abstract][Full Text] [Related]
15. Alternatively spliced MDM2 transcripts in human breast cancer in relation to tumor necrosis and lymph node involvement.
Hori M; Shimazaki J; Inagawa S; Itabashi M; Hori M
Pathol Int; 2000 Oct; 50(10):786-92. PubMed ID: 11107050
[TBL] [Abstract][Full Text] [Related]
16. Novel mdm2 splice variants identified in pediatric rhabdomyosarcoma tumors and cell lines.
Bartel F; Taylor AC; Taubert H; Harris LC
Oncol Res; 2001; 12(11-12):451-7. PubMed ID: 11939408
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of Mdm2 and MdmX fusion proteins alters p53 mediated transactivation, ubiquitination, and degradation.
Ghosh M; Huang K; Berberich SJ
Biochemistry; 2003 Mar; 42(8):2291-9. PubMed ID: 12600196
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of the MDM2 oncogene in leukemia and lymphoma.
Watanabe T; Ichikawa A; Saito H; Hotta T
Leuk Lymphoma; 1996 May; 21(5-6):391-7, color plates XVI following 5. PubMed ID: 9172803
[TBL] [Abstract][Full Text] [Related]
19. Nucleolar p14(ARF) overexpression in Reed-Sternberg cells in Hodgkin's lymphoma: absence of p14(ARF)/Hdm2 complexes is associated with expression of alternatively spliced Hdm2 transcripts.
García JF; Villuendas R; Sánchez-Beato M; Sánchez-Aguilera A; Sánchez L; Prieto I; Piris MA
Am J Pathol; 2002 Feb; 160(2):569-78. PubMed ID: 11839577
[TBL] [Abstract][Full Text] [Related]
20. p53 and MDM2 in the development and progression of bladder cancer.
Schmitz-Dräger BJ; Kushima M; Goebell P; Jax TW; Gerharz CD; Bültel H; Schulz WA; Ebert T; Ackermann R
Eur Urol; 1997; 32(4):487-93. PubMed ID: 9412812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
